|
Bringing over 25 years of Pathology experience to the company, Celerus is the third company in the field of Pathology founded by Mr. Erickson. Most recently he acted as VP, IHC for Chemicon International, establishing and operating an IHC and Molecular Anatomy Research Facility and introducing over 175 new products to the market. Prior to Chemicon, Mr. Erickson co-founded QualTek Molecular Labs, Inc. which provides IHC and ISH contract research services to BioPharma, BioTech, and University Laboratories. He also co-founded BioTek Solutions which designed and built instrumentation and detection systems that automated IHC and ISH assays, and was successfully acquired by Ventana Medical Systems (NASDAQ: VMSI) in 1996. His previous positions include Director of the Biological Microscopy Facility and Lecturer at University of California, Santa Barbara. He holds several patents in the area of automated IHC, ICC and ISH. Mr. Erickson holds a BA in Cellular and Oganismal Biology, a PhD in Cell Biology, and Postdoctoral Training in Molecular Biology from the University of California, Santa Barbara. | 